hydantoins has been researched along with Death, Sudden, Cardiac in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharucha, DB; Dorian, P; Kowey, PR; Mahaffey, KW; Robinson, VM | 1 |
| Grönefeld, GC; Hohnloser, SH | 1 |
| Pratt, CM | 1 |
| Black, SC; Butterfield, JL; Lucchesi, BR | 1 |
| Camm, AJ; Karam, R; Pratt, CM | 1 |
2 review(s) available for hydantoins and Death, Sudden, Cardiac
| Article | Year |
|---|---|
[Drug therapy of ventricular arrhythmias - a contemporary perspective].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hydantoins; Imidazoles; Imidazolidines; Meta-Analysis as Topic; Piperazines; Placebos; Primary Prevention; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Risk Factors; Time Factors | 2002 |
Pure class III agents for prevention of sudden cardiac death.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Comorbidity; Death, Sudden, Cardiac; Europe; Humans; Hydantoins; Imidazoles; Imidazolidines; Middle Aged; Myocardial Infarction; Phenethylamines; Piperazines; Randomized Controlled Trials as Topic; Sotalol; Sulfonamides; Survival Analysis; Treatment Outcome | 2003 |
2 trial(s) available for hydantoins and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial.
Topics: Aged; Anti-Arrhythmia Agents; Cardiovascular Diseases; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Early Termination of Clinical Trials; Electric Countershock; Emergency Service, Hospital; Female; Heart Failure; Hospitalization; Humans; Hydantoins; Male; Middle Aged; Odds Ratio; Piperazines; Proportional Hazards Models; Stroke Volume; Tachycardia, Ventricular; Ventricular Fibrillation | 2017 |
The azimilide post-infarct survival evaluation (ALIVE) trial.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Middle Aged; Myocardial Infarction; Piperazines; Risk Factors; Stroke Volume; Survival Rate | 1998 |
2 other study(ies) available for hydantoins and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
Topics: Animals; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Electrophysiology; Heart Rate; Hydantoins; Imidazoles; Imidazolidines; Male; Myocardial Infarction; Piperazines; Piperidines; Tachycardia, Ventricular; Ventricular Fibrillation | 1993 |
Electrophysiology test may predict SCD (sudden cardiac death) risk: investigators induce VT in CAD patients.
Topics: Anti-Arrhythmia Agents; Coronary Disease; Death, Sudden, Cardiac; Electrophysiology; Humans; Hydantoins; Imidazoles; Imidazolidines; Piperazines; Risk Assessment; Tachycardia, Ventricular; United States | 1999 |